BioMarin Pharmaceutical Goodwill and Intangible Assets 2010-2024 | BMRN
BioMarin Pharmaceutical goodwill and intangible assets for the quarter ending December 31, 2024 were $0.451B, a 8.03% decline year-over-year.
- BioMarin Pharmaceutical goodwill and intangible assets for 2024 were $0.451B, a 8.03% decline from 2023.
- BioMarin Pharmaceutical goodwill and intangible assets for 2023 were $0.491B, a 8.2% decline from 2022.
- BioMarin Pharmaceutical goodwill and intangible assets for 2022 were $0.535B, a 8.56% decline from 2021.